What is the cause of hyponatremia (low sodium levels in the blood) with a urine sodium of 10 mEq/L (milliequivalents per liter), serum osmolality of 249 mOsm/kg (milliosmoles per kilogram), and urine osmolality of 227 mOsm/kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The cause of hyponatremia (sodium level of 114 mEq/L) with low urine sodium (10 mEq/L), low serum osmolality (249 mOsm/kg), and low urine osmolality (227 mOsm/kg) is most likely hypovolemic hyponatremia due to extrarenal fluid losses, as suggested by the low urine sodium and low serum osmolality, which is consistent with the body's attempt to conserve sodium in response to volume depletion 1. This pattern suggests that the body is appropriately conserving sodium in response to volume depletion. Common causes include vomiting, diarrhea, excessive sweating, or third-spacing of fluids as in pancreatitis, burns, or peritonitis.

  • The low serum osmolality confirms true hyponatremia rather than pseudohyponatremia.
  • The urine osmolality being close to the serum osmolality indicates the kidneys are attempting to excrete free water but are limited by the hypovolemic state.
  • Once volume status improves, urine osmolality would typically increase as ADH levels normalize in response to restored blood volume. Treatment should focus on addressing the underlying cause of fluid loss and carefully replacing both sodium and volume with isotonic saline (0.9% NaCl) 1.
  • Initial correction should not exceed 6-8 mEq/L in 24 hours to avoid osmotic demyelination syndrome, especially with severe, chronic hyponatremia.
  • The use of vaptans, such as tolvaptan, may be considered in the treatment of hypervolemic hyponatremia, but its use should be carefully monitored to avoid rapid correction of sodium levels 1.
  • Albumin infusion may also be considered to improve serum sodium concentration, but more information is needed 1. It is essential to note that the management of hyponatremia in patients with cirrhosis requires careful consideration of the underlying pathophysiology and the potential risks and benefits of different treatment strategies 1.

From the Research

Causes of Hyponatremia

  • The patient's serum sodium level is 114 mmol/L, which is lower than the normal range of 135-145 mmol/L 2, 3, 4, 5, 6.
  • The urine sodium level is 10 mmol/L, which is relatively low, and the serum osmolality is 249 mosmol/kg, while the urine osmolality is 227 mosmol/kg 4.
  • These values suggest that the patient may have a condition known as the syndrome of inappropriate antidiuretic hormone secretion (SIADH), which is characterized by excessive secretion of antidiuretic hormone (ADH) leading to water retention and hyponatremia 2, 4, 6.

Diagnosis of SIADH

  • The diagnosis of SIADH is confirmed by decreased serum osmolality, inappropriately elevated urine osmolality (>100 mosmol/L), and elevated urine sodium (Na) levels 4.
  • However, in this case, the urine sodium level is low (10 mmol/L), which may not be consistent with SIADH 4.
  • Other causes of hyponatremia, such as hypovolemia, heart failure, or liver disease, should also be considered and ruled out 3, 5, 6.

Treatment Options

  • The treatment of hyponatremia depends on the underlying cause and the severity of the condition 3, 4, 5, 6.
  • For patients with SIADH, fluid restriction is often the primary treatment, while for patients with hypovolemia, isotonic saline infusion may be necessary 3, 4.
  • Tolvaptan, a vasopressin V2-receptor antagonist, may be effective in increasing serum sodium concentrations in patients with euvolemic or hypervolemic hyponatremia 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD).

Therapeutic advances in endocrinology and metabolism, 2023

Research

Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2006

Related Questions

What is the appropriate management for a young female with a 2-week history of cough and fever, presenting with hypokalemia and specific serologic test results?
What treatment is recommended for a 30-year-old male who consumed 50 ml of distilled water with no complaints or symptoms?
How to manage a 54-year-old man with severe dehydration, electrolyte imbalance, and muscle spasms due to watery diarrhea and vomiting?
How to manage post-operative anemia, thrombocytopenia, and electrolyte imbalances in a patient with nausea and poor oral intake?
What is the management for a traveler with severe diarrhea, high fever, and syncope?
What is the management approach for a patient with Chronic Obstructive Pulmonary Disease (COPD) Anthonisen type II, Medical Research Council (MRC) grade 2, and CAT score of 21, exacerbated by community-acquired pneumonia, with a CURB-65 score of 2 and PSI (Pneumonia Severity Index) score of 108, and comorbidities including type 2 Diabetes Mellitus, systemic arterial Hypertension, grade III normocytic hypochromic Anemia according to the World Health Organization (WHO), FRAIL (Fatigue, Resistance, Ambulation, Illness, and Loss of weight) score of 4, high risk of pressure ulcers, and normal nutritional status?
What is the diagnosis and treatment for Hidradenitis suppurativa (Acne inversa)?
What is the role of Nubeqa (darolutamide) in the treatment of a patient with stage IV, bone-metastatic, castration-sensitive prostate cancer, Gleason score 9, and elevated Prostate-Specific Antigen (PSA) levels?
Can you perform an analysis with these diagnoses?
What is the analysis of a patient with Chronic Obstructive Pulmonary Disease (COPD) Anthonisen type II, Medical Research Council (MRC) grade 2, COPD Assessment Test (CAT) score of 21, exacerbated by Community-Acquired Pneumonia (CAP) with CURB-65 score of 2 and Pneumonia Severity Index (PSI) score of 108, class IV risk, and comorbidities including Type 2 Diabetes Mellitus, Systemic Arterial Hypertension, grade III normocytic hypochromic Anemia according to the World Health Organization (WHO), Fragile syndrome with a FRAIL score of 4, high risk of Pressure Ulcers with a Norton score of 10, and normal nutritional status with a Mini Nutritional Assessment-Short Form (MNA-SF) score of 12?
What is the analysis of a patient with Chronic Obstructive Pulmonary Disease (COPD) Anthonisen type II, Medical Research Council (MRC) grade 2, COPD Assessment Test (CAT) score of 21, exacerbated by Community-Acquired Pneumonia (CAP) with CURB-65 score of 2 and Pneumonia Severity Index (PSI) score of 108, class IV risk, and comorbidities including Type 2 Diabetes Mellitus, Systemic Arterial Hypertension, grade III normocytic hypochromic Anemia according to the World Health Organization (WHO), Fragile syndrome with a FRAIL score of 4, high risk of Pressure Ulcers with a Norton score of 10, and normal nutritional status with a Mini Nutritional Assessment-Short Form (MNA-SF) score of 12?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.